Neurorehabilitation Devices Market - By Product: Robotic Systems, BCIs; By End User: Hospitals, Home Care; By Region: North America, Europe, Asia-Pacific Latin America and Others
Market Overview:
The neurorehabilitation devices market encompasses robotic exoskeletons, brain-computer interfaces (BCIs), non-invasive stimulators, and virtual reality (VR) systems designed to restore motor and cognitive function in patients with stroke, spinal cord injuries, Parkinson’s disease, and multiple sclerosis. This market is driven by the increasing prevalence of neurological disorders, aging populations, and technological advancements, moving towards home-based, AI-driven rehabilitation.
Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2023 |
2.1 |
Dominated by robotic gait trainers (45% share). |
|
2028 |
5.8 |
CAGR 22.5% (2023–2028); VR/BCI adoption soars. |
|
2035 |
14.3 |
CAGR 18.7% (2028–2035); home-use devices claim 40% share. |
1.2 million+ devices in use by 2035, with 60% deployed in post-stroke rehab.
Market Drivers
Market Challenges
Competitive Landscape
|
Company |
2023 Share |
Core Strengths |
Recent Moves |
|
Hocoma (DKSH) |
30% |
Robotic gait trainers |
Launched AI-powered Lokomat (2024). |
|
Ekso Bionics |
20% |
Exoskeletons for stroke |
Won USD 40M DoD contract (2025). |
|
Neuroelectrics |
15% |
Non-invasive tDCS/tACS |
FDA-cleared Starstim for home use (2025). |
|
Startups (e.g., MindMaze) |
35% |
VR neurorehab |
Raised USD 200M for PTSD therapy (2024). |
Market Segmentation
|
Segment |
2023 Share |
CAGR (2023–2035) |
|
By Product |
||
|
Robotic Systems |
45% |
20.1% |
|
BCIs |
15% |
28.5% |
|
By End User |
||
|
Hospitals |
50% |
17.8% |
|
Home Care |
30% |
25.4% |
Regional Analysis
Technology & Innovation
Regulatory Environment
Strategic Outlook
Need help?
Chat with our team in a minute.